Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast Milk
Open Access
- 15 October 2002
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 186 (8), 1173-1176
- https://doi.org/10.1086/343805
Abstract
Secretory leukocyte protease inhibitor (SLPI), a protein found in saliva, breast milk, and genital secretions, is capable of inhibiting human immunodKeywords
This publication has 13 references indexed in Scilit:
- Identification of a novel secretory leukocyte protease inhibitor‐binding protein involved in membrane phospholipid movementFEBS Letters, 2000
- Secretory leukocyte protease inhibitor in colostrum and breast milk is not a major determinant of the protection of early postnatal transmission of HIVAIDS, 1999
- Endogenous Mucosal Antiviral Factors of the Oral CavityThe Journal of Infectious Diseases, 1999
- Cervical Human Immunodeficiency Virus Type 1 Shedding Is Associated with Genital β‐Chemokine SecretionThe Journal of Infectious Diseases, 1998
- Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.1997
- Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1Oral Diseases, 1997
- Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1Epidemiologic Reviews, 1996
- Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.Journal of Clinical Investigation, 1995
- Orogenital sex and the transmission of HIV among homosexual menAIDS, 1992
- ASSOCIATION BETWEEN BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS VARIANTS AND RISK FOR AIDS AND AIDS MORTALITYThe Lancet, 1989